VentureBeat May 2, 2024
Carl Franzen

In a major leap in medical imaging, Israeli startup AISAP announced today that it has secured $13 million in seed funding for its product: an AI-powered software platform that connects to common ultrasound wands and sensors to provide rapid assessment of patients’ conditions for physicians — even those doctors and medical professionals without any formal training in analyzing ultrasound imagery.

AISAP’s Point-of-Care Assisted Diagnosis (POCAD) delivers results in as little as five minutes, compared to other ultrasound procedures that can take hours or even days for results to become available, as they are limited by the availability of radiologists who can interpret images and the labs where said images are processed.

“The problem that we’re addressing is actually the fact...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Investments, Provider, Technology, Trends
How Technology is Changing Alzheimer’s and Dementia Testing
AI on the Agenda at 2024 ATS, Says Conference Chair | 2024 ATS
HIMSSCast: Biden's executive order on AI is just the beginning
IHI report: The main use cases for genAI, their risks and ways to mitigate
How Businesses Can Navigate the AI Search Shake-Up

Share This Article